Cite
Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort.
MLA
Pironi, Loris, et al. “Candidacy of Adult Patients with Short Bowel Syndrome for Treatment with Glucagon-like Peptide-2 Analogues: A Systematic Analysis of a Single Centre Cohort.” Clinical Nutrition, vol. 40, no. 6, June 2021, pp. 4065–74. EBSCOhost, https://doi.org/10.1016/j.clnu.2021.02.011.
APA
Pironi, L., Sasdelli, A. S., Venerito, F. M., Musio, A., Pazzeschi, C., & Guidetti, M. (2021). Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort. Clinical Nutrition, 40(6), 4065–4074. https://doi.org/10.1016/j.clnu.2021.02.011
Chicago
Pironi, Loris, Anna Simona Sasdelli, Francesca Maria Venerito, Alessandra Musio, Caterina Pazzeschi, and Mariacristina Guidetti. 2021. “Candidacy of Adult Patients with Short Bowel Syndrome for Treatment with Glucagon-like Peptide-2 Analogues: A Systematic Analysis of a Single Centre Cohort.” Clinical Nutrition 40 (6): 4065–74. doi:10.1016/j.clnu.2021.02.011.